Emergency room breakthrough? High-Dose addiction treatment trial aims to curb fentanyl crisis
NCT ID NCT05589181
Summary
This study is testing if starting people on a higher dose of the addiction medication buprenorphine in the emergency room is safe and helps more people get into follow-up treatment. It focuses on people with opioid addiction who test positive for fentanyl. The goal is to see if a higher initial dose leads to better engagement in comprehensive care within the first week.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rutgers University Hospital
RECRUITINGNewark, New Jersey, 07103, United States
Conditions
Explore the condition pages connected to this study.